John E. Weldon

A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity

John E. Weldon, Laiman Xiang, Oleg Chertov et al. · Blood · 2008 · 164 citations · Full text

Medicine, Immunology, Toxicology +4

Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes

Masanori Onda, Richard Beers, Laiman Xiang et al. · Proceedings of the National Academy of Sciences · 2011 · 105 citations

Life Sciences, Immunology, Pharmacology +15

A Recombinant Immunotoxin against the Tumor-Associated Antigen Mesothelin Reengineered for High Activity, Low Off-Target Toxicity, and Reduced Antigenicity

John E. Weldon, Laiman Xiang, Jingli Zhang et al. · Molecular Cancer Therapeutics · 2012 · 93 citations · Full text

Life Sciences, Biotechnology, Immunology +17

Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on <i>Pseudomonas</i> exotoxin A

Ronit Mazor, Aaron Vassall, Jaime Eberle-Singh et al. · Proceedings of the National Academy of Sciences · 2012 · 88 citations · Full text

Life Sciences, Immunology, Cancer Immunology +16

The Gene ygdP, Associated with the Invasiveness ofEscherichia coli K1, Designates a Nudix Hydrolase, Orf176, Active on Adenosine (5′)-Pentaphospho-(5′)-adenosine (Ap5A)

Maurice Bessman, Joseph D. Walsh, Christopher Dunn et al. · Journal of Biological Chemistry · 2001 · 80 citations · Full text

Life Sciences, Microbiology, Molecular Biology +12